pCDCAR1 EGFRvIII h(ICOSζ)(CAR-MZ028)
The vector of anti-EGFRvIII chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human EGFRvIII. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-EGFRvIII antibody linked to ICOS and CD3ζ signaling domains. And the vector product was designed for the treatment of EGFRvIII expressing glioma.
Targeting Cell Type
EGFRvIII expressing glioma
Discription of Signaling Cassetes
CD278 or ICOS (Inducible T-cell COStimulator) is a CD28-superfamily costimulatory molecule that is expressed on activated T cells. It is thought to be important for Th2 cells in particular. The protein encoded by this gene belongs to the CD28 and CTLA-4 cell-surface receptor family. It forms homodimers and plays an important role in cell-cell signaling, immune responses, and regulation of cell proliferation.
CD3ζ, also known as T-cell receptor zeta, which together with T-cell receptor and CD3γ, δ , ε chain, forms the TCR-CD3 complex. ζ was expressed independently from the complex. The zeta chain plays an important role in coupling antigen recognition to several intracellular signal-transduction pathways. CD3-zeta, which contains 3 ITAMs, is the most commonly used endodomain component of CARs. It transmits an activation signal to the T cell after antigen is bound. CD3-zeta may not provide a fully competent activation signal and additional co-stimulatory signaling is needed. For example, chimeric CD28 and OX40 can be used with CD3-zeta to transmit a proliferative/survival signal, or all three can be used together.
epidermal growth factor receptor
EGFR; epidermal growth factor receptor; ERBB; HER1; mENA; ERBB1; PIG61; NISBD2; Melanoma; CD28; Chimeric antigen receptor; T cell; Retrovirus; CARs; Lentivirus; chimeric T cell receptors; chimeric immunoreceptors; chimeric antigen receptors; scFv
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
||Lenti-EGFRvIII CAR (scFv-CD28-CD3ζ, 3C10) Viral Particle
||Anti-EGFR (R1) h(CD3ζ) CAR, Pcdcar1
||Anti-EGFRvIII scFv h(CD28-FcεRIγ) CART, pCDCAR1
||Lenti-EGFRvIII CAR (scFv-CD3ζ, 131) Viral Particle
||Anti-EGFRvIII scFv h(b2c-CD3ζ) CART, pCDCAR1
||Lenti-EGFRvIII CAR (scFv-CD28-CD3ζ, 13.1.2) Viral Particle
||Anti-EGFR (Cetuximab) h(CD28-CD3ζ) CAR, pCDCAR1
||Lenti-EGFRvIII CAR (scFv-CD28-41BB-CD3ζ, RAbDMvIII) Viral Particle
||Lenti-EGFR CAR (scFv-41BB-CD3ζ, Nimotuzumab) Viral Particle
||Anti-EGFRvIII (MR1.1) h(CD28-CD3ζ) CAR, pCDCAR1